On April 30, 2026, the Department of Justice (“DOJ”) announced the creation of the West Coast Health Care Fraud Strike Force, a coordinated enforcement initiative focused on healthcare fraud in Arizona, Nevada, and Northern California. The initiative brings together DOJ’s
Ten People Died. Where Did the Boar’s Head Investigations Go? Hello DOJ and USDA Inspector General?
When ten people die in a Listeria outbreak traced to a single plant with a documented, years-long record of filth, I pay attention to what the government promises to do about it. And I keep a calendar.
By that calendar,
A Response to the Big Beautiful Bill: Seven Days in June
In Englewood Hospital & Medical Center v. State of New Jersey decided in July 2025, the New Jersey Supreme Court acknowledged the decades-old legislative declaration that it is of paramount public interest for the State to take all necessary and
Lawyer in Vietnam Dr. Oliver Massmann – From Biodiversity to Biotechnology: Why Vietnam May Be Asia’s Next Undervalued Investment Opportunity
Foreign investors often look at Vietnam through familiar lenses: manufacturing, exports, infrastructure, renewable energy, real estate, and digital transformation.Yet one of Vietnam’s most compelling future investment stories may come from a very different source: its biodiversity.Vietnam is one of the
Still Grounded: Why Rescheduling Doesn’t Mean Truckers and Pilots Can Light Up
Good news for people who don’t want their airline pilots any higher than they already are.
If you’ve been following the rescheduling saga as closely as I have, you might have assumed that once President Trump signed the executive order
Product Representatives are Not Surgical Supervisors: No Duty to Grab the Scalpel
Medical device sales representatives are many things. They know their product lines inside and out. They can tell a surgeon exactly where to find a particular screw, rod, or connector in a tray containing dozens of components. They can help
FDA Publishes Draft Guidance on Three-Year New Clinical Investigation Exclusivity
Since 1984, FDA has had authority to recognize three years of regulatory exclusivity for certain qualifying new drug applications that conduct new clinical investigations essential for its approval. Despite no shortage of controversy, nuance, challenges, and litigation in the intervening
Medical: ECT treatment of an involuntary patient (appeal).
KLH v Northern NSW Local Health District [2026] NSWSC 590 (Link to Caselaw)
These proceedings constituted an appeal under section 163 of the Mental Health Act 2007 NSW from a determination made on 30 March 2026 by the Mental Health Review Tribunal , granting an application by an
Medical: Settlement approval rejected.
Cleary v Illawarra Shoalhaven Local Health District (No 2) [2026] NSWSC 618 (Link to Caselaw).
In this second application for approval of a settlement by a person under a disability there were shortcomings in the material provided, precluding a
Risk Analysis in the Crosshairs: Four Recent Ransomware Resolutions Preview the HIPAA Security Rule Amendments
On April 23, 2026, the U.S. Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR) announced resolution agreements and corrective action plans with four regulated entities following separate ransomware investigations under the Health Insurance Portability and Accountability